@celtliverpool
The Centre of Excellence for Long-acting Therapeutics (CELT) at #livuni is accelerating understanding of #longacting medicines, by combining world leading expertise in pharmacology and materials chemistry to create new interventions.
📣FULLY FUNDED PhD STUDENTSHIP
The Perinatal Pharmacology Group are recruiting a fully funded PhD student that will involve working with us (Centre of Excellence for Long-acting Therapeutics - Global Health).
Deadline: 20 March 2026
Find out more: www.liverpool.ac.uk/celt-global-...
Dr Marcia Vermeulen is behind a lectern presenting a talk at the University of Cape Town. The blog title is written over the top "From vision to impact: Redefining STEM by closing the gender gap with Dr Marcia Vermeulen".
In this piece, Dr Marcia Vermeulen tells us about her research journey including work with the #LONGEVITYproject on our tuberculosis community engagement work.
As it was International Women's Day yesterday we're sharing it again for you.
www.liverpool.ac.uk/celt-global-...
@unitaid.bsky.social
The skyline of Nairobi city in Kenya as the sun rises.
This week's news from other long-acting therapeutics teams:
💉Kenya launches long-acting HIV prevention injection
🏭South Africa launch bid to enable local production of lenacapavir
🧪ViiV Healthcare report two long-acting HIV treatment findings
www.liverpool.ac.uk/celt-global-...
@unitaid.bsky.social
🧵2/2
🌍Lead stakeholder engagement across global networks and strengthen partnerships across the @unitaid.bsky.social funded Community of Practice
🗣️Run surveys, workshops and evidence‑gathering activities
📑Support production of quality evidence syntheses, best‑practice resources and policy outputs.
An colourful image of the University of Liverpool. The text reads "Stakeholder Engagement Officer, Grade 7 (£39,906 - £46,049pa), full time working hours, fixed term until 31 December 2027, on the Liverpool campus".
🧵1/2
📣JOB ADVERT!
🌟Stakeholder Engagement Officer
Join a team accelerating long‑acting medicines for maternal and children's health priorities worldwide, within the Perinatal Pharmacology group with Dr @aeolagunju, Prof Andrew Owen and Prof Steve Rannard
www.liverpool.ac.uk/celt-global-...
A solar system made up of "materials chemistry + pharmacology + regulatory expertise + community engagement = new long-acting medicines"
#LONGEVITYproject is a consortium researching long-acting malaria and TB preventatives, and a one-shot cure for patients with hepatitis C virus.
We explain more about LONGEVITY on our website, including pages about the work for each disease:
www.liverpool.ac.uk/celt-global-...
@unitaid.bsky.social
An image of a bridge in the sunshine. Text reads "LAAI2026, 2nd international workshop on long-acting anti-infectives. Hybrid workshop, 20-21 May 2026, Philadelphia, United States. Save the date! Abstract submission deadline: Friday 13 March 2026"
We have a few events on our events page, including our next Community of Practice webinar and BSNM's annual meeting.
The abstract deadline for @academicmededu.bsky.social's 2nd International Workshop on Long-acting anti-infectives is next Friday, 13 March.
www.liverpool.ac.uk/celt-global-...
a person is receiving an injection by a medical professional.
This week's global long-acting news from other groups:
@tevapharm.bsky.social NDA for a once-monthly treatment for adults with schizophrenia accepted by @US_FDA
ViiV reports long-acting cabenuva effective in adolescents living with HIV, with >97% preferring LAIs
www.liverpool.ac.uk/celt-global-...
HALo's logo is a celtic knot with the word "HALo" to the right of it and "CELT Global Health" beneath that.
HALo-UK Hub for Advanced Long-acting Therapeutics aims include:
🧪Accelerate LAT development
🗣️Advocate for national LAT strategy
🔗An evidence-based pathway to scale-up industrial and academic LAT candidates
📑A regulatory environment for rapid clinical evaluation.
www.liverpool.ac.uk/celt-global-...
An LA-LINK flyer with a bulb glowing about a global heat map. The text reads "LA-LINK Workshop Series; what would you like to see?"
We'll announce the theme for the next of our recurring online seminar and workshop series, LA-LINK, in the coming weeks.
In the meantime, we'd be interested to know if there are any topics you'd like to see included in this workshop series?
www.liverpool.ac.uk/celt-global-...
@unitaid.bsky.social
Mycobacterium Tuberculosis Bacteria Scanning electron micrograph of Mycobacterium tuberculosis particles (colorized blue), the bacterium which causes TB. Credit: NIAID
This week's news from other long-acting teams:
@ubuffalo.bsky.social develop long-acting inhalable tuberculosis treatment
ViiV Healthcare announce efficacy of long-acting HIV treatment compared to daily pills for patients who have experienced adherence challenges
www.liverpool.ac.uk/celt-global-...
A recording of LA-LINK's ‘Application of pharmacokinetic modelling and simulation for long-acting medicines’ workshop is now available!
Among the talks Harshal Hattyangdi demonstrated the new Teoreler 2.0 free online modelling software that we launched that day.
youtu.be/_pF44HL06zw?...
A woman looks over the land at the sunrise. Text reads "Subscribe to our mailing list"
Are you signed up the #LONGEVITYproject newsletter?
Every quarter we send an email updating you with news from the last few months, and let you know about upcoming LONGEVITY relevant events and opportunities.
You can subscribe via the link: www.liverpool.ac.uk/celt-global-...
@unitaid.bsky.social
A magnified image of an HIV virus.
Recent Global News from other long-acting research teams:
💊Health Gap demand an access strategy for Merck's new long-acting oral HIV preventative for LMICs
💉@stjuderesearch.bsky.social find long-acting injectable HIV treatment is safe and preferred by adolescents
www.liverpool.ac.uk/celt-global-...
People at a conference are applauding and smiling at each other. The word "event" is written over the top.
Exciting things on our events page:
- We're presenting at CROI later this month
- Our next Community of Practice webinar is in March
- British Society for Nanomedicine announced their annual conference. Abstract submission deadline is Friday 30 June.
Learn more: www.liverpool.ac.uk/celt-global-...
Dr Marcia Vermeulen is behind a lectern presenting a talk at the University of Cape Town. The blog title is written over the top "From vision to impact: Redefining STEM by closing the gender gap with Dr Marcia Vermeulen".
For @unesco.org's International Day of Women and Girls in Science, we spoke to Dr Marcia Vermeulen from University of Cape Town, who oversaw #LONGEVITYproject tuberculosis community engagement work with patients and providers: www.liverpool.ac.uk/celt-global-...
#February11
@unitaid.bsky.social
🧵4/4
Our malaria work, towards an understanding of a long-acting malaria preventative using a microarray patch, works differently to the other two diseases.
We've written a short bullet point breakdown of the milestones on our LONGEVITY malaria page: www.liverpool.ac.uk/celt-global-...
🧵3/4
The hepatitis C virus page has a map of our milestones to get from an idea for a one-shot treatment for HCV all the way through to clinical trial.
Below the map is further written explanation.
The hepatitis C virus map is on the LONGEVITY HCV page: www.liverpool.ac.uk/celt-global-...
🧵2/4
For our long-acting tuberculosis preventative work, we've created a map of the milestones from each section of the journey to show you roughly where we're up to.
Below the map is an explanation of each 'stop'.
The TB map is on our LONGEVITY TB page: www.liverpool.ac.uk/celt-global-...
a blurred image to tease a LONGEVITY map
🧵1/4
We're trying to make sure our work on the #LONGEVITYproject is as transparent as possible.
Funded by @unitaid.bsky.social, we've created a breakdown of what the work for each disease looks like.
We hope an accessible explanation will help show the journey of each disease.
🧵2/2
The plan is to do this by co-creating a resource developed with country partners, experts, and end users, that helps developers design and deliver long-acting formulations for diseases such as tuberculosis and hepatitis C virus, through applying implementation science.
🧵1/2
One of the activities within our grant from global health agency @unitaid.bsky.social is an Implementation Research project.
Working with @lstmnews.bsky.social and LVCT Health, we aim to support person-centred long-acting treatments for chronic infectious diseases in LMICs.
Our Community of Practice for long-acting therapeutics for maternal and paediatric health published a paper!
'Advancing maternal health with long-acting therapeutics: Priorities, efficacy and safety considerations, and emerging technologies' in Clinical Pharmacology and Therapeutics.
bit.ly/3Mhhr0d
The LAPaL logo is the word LAPaL with 'the long-acting therapeutics patents and licences database' underneath.
LAPaL provides long-acting medicinal product and drug delivery technology data
Recently added:
Risperidone LAI
PGT-121
PGT-121.144.LS
TLC ART combination therapy
PGT-121.144.LS + VRC07-523LS
Rifapentine
Gemcitabine intravesical LAI system
www.liverpool.ac.uk/celt-global-...
@medicinespatentpool.org
Teoreler 2.0 will be available to use after it's demonstration at the first LA-LINK workshop this afternoon (29 January, 2pm GMT).
Contact us on askcelt@liverpool.ac.uk for a link to join the demonstration at ‘Application of pharmacokinetic modelling and simulation for long-acting medicines’.
Dr Rajith Rajoli is sat at his computer working on some PBPK models
📣NEWS!
We're excited to announce Teoreler 2.0!
While our team always work hard to bring new and updated models, Teoreler 2.0 has new and more streamlined features to make your PBPK modelling journey easier.
Find out more in our news story: www.liverpool.ac.uk/celt-global-...
@unitaid.bsky.social
Dr Brenda Okware is standing at the lectern smiling at the audience, while panel Chair Dr Grace Miheso is smiling at her. The blog title is written over the top "Holding ground on maternal health: CELT Global Health are committed"
23 January is #MaternalHealthAwarenessDay
It's one year since we launched our Community of Practice for long-acting therapeutics for maternal and paediatric health.
Stakeholder Engagement Coordinator Rachel Daley has written a piece for us:
www.liverpool.ac.uk/celt-global-...
@unitaid.bsky.social
The Manufacturing Capability logo is the project title to the right of a celtic knot and "CELT Global Health" underneath.
Our Manufacturing Capability project is creating a global resource showcasing what long-acting capabilities different international manufacturers have.
We believe that local manufacturing is key to address medication inequality.
Find out more: www.liverpool.ac.uk/celt-global-...
@unitaid.bsky.social
A solar system made up of "materials chemistry + pharmacology + regulatory expertise + community engagement = new long-acting medicines"
Are you subscribed to our #LONGEVITYproject newsletter?
A quarterly update of the international consortium work (funded by @unitaid.bsky.social) to bring long-acting treatments or preventatives to patients with tuberculosis, hepatitis C virus and malaria in LMICs
www.liverpool.ac.uk/celt-global-...
Dr Rajith Rajoli is using modelling software on their computer. Over the image reads "Teoreler: A web-based physiologically based pharmacokinetic (PBPK) modelling application for the simulation and extrapolation of drug use scenarios. This application simulates drug pharmacokinetics of small molecules using complex mathematical equations to predict the efficacy of drugs in the human body in a variety of species and populations."
We're demonstrating Teoreler 2.0, the new version of our free online PBPK modelling simulation app, at our first online LA-LINK workshop.
You'll learn about new features, improved user experience and more at the free event Thursday 29 January: www.liverpool.ac.uk/celt-global-...
@unitaid.bsky.social